# active_site_0014: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/active_site_0014.txt)

**Task:** `active_site`  
**Author key, unchanged:** **B** — Position 113 (Glycyl thioester intermediate)

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MISAPSPDHLLLEQDLATPEIRCGEIEERWRHIRTSWPHVFFAVSAPQRPNGPKEFGFRFEYTGYRQTPVTAQLWDLEADAPLPHAKWPTGTYVVPSVFRKDWQQGNCLYIPCDRISIQGHTAWLNDHPSRLWQPARGIICYLEQLYELFNQGDYTGLVSA

[Multiple Choices]
A. Position 154 (Nucleophile)
B. Position 113 (Glycyl thioester intermediate)
C. Position 1142 (Proton donor; for dehydratase activity 1)
D. Position 4261 (For beta-ketoacyl synthase 3 activity)
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result.

Citations as saved: [H2](#evidence-h2), [H3](#evidence-h3), [C5](#evidence-c5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.


**Missing item-specific fact**

> Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.


**Reason**

> The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length.


### Important caveats

- The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.
- The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.",
    "reason": "The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "H2",
      "H3",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result."
  },
  "important_caveats": [
    "The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.",
    "The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result.",
    "evidence_ids": ["H2", "H3", "C5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.",
    "missing_item_specific_fact": "Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.",
    "reason": "The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length."
  },
  "important_caveats": [
    "The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.",
    "The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.


**Missing item-specific fact**

> The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.


**Reason**

> While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices.


### Important caveats

- The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.
- The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.
- Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.
- The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.",
    "reason": "While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.",
    "The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.",
    "Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.",
    "The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support.",
    "evidence_ids": ["C5", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.",
    "missing_item_specific_fact": "The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.",
    "reason": "While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.",
    "The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.",
    "Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.",
    "The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates position 113 as the active site for a glycyl thioester intermediate. Its cited reference concerns mutagenesis of Cys-113, though the supplied excerpts do not give the experimental result itself; the annotation is curator-supported rather than direct experimental evidence shown here.

Citations as saved: [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The input sequence is 161 residues long, and position 113 is cysteine. A catalytic cysteine can form a thioester with a substrate's terminal glycine, making B a coherent transferable biochemical inference. Positions 1142 and 4261 are outside the sequence, while position 154 is tyrosine, which is a poor fit for the stated nucleophile role.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence and the thioester mechanism described in the choices provide a meaningful basis for preferring B without needing the target's database record. This supports a plausible inference, not independent confirmation of the particular protein's activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The other options are inconsistent with the sequence length or with the residue and mechanism at the stated position.


### Important caveats

- The evidence supports a sequence-matched database annotation citing a mutagenesis reference; the supplied excerpts do not independently establish the experiment's outcome.
- The option describes the glycyl thioester intermediate rather than explicitly naming cysteine as the residue type.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The input sequence is 161 residues long, and position 113 is cysteine. A catalytic cysteine can form a thioester with a substrate's terminal glycine, making B a coherent transferable biochemical inference. Positions 1142 and 4261 are outside the sequence, while position 154 is tyrosine, which is a poor fit for the stated nucleophile role.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence and the thioester mechanism described in the choices provide a meaningful basis for preferring B without needing the target's database record. This supports a plausible inference, not independent confirmation of the particular protein's activity."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates position 113 as the active site for a glycyl thioester intermediate. Its cited reference concerns mutagenesis of Cys-113, though the supplied excerpts do not give the experimental result itself; the annotation is curator-supported rather than direct experimental evidence shown here."
  },
  "important_caveats": [
    "The evidence supports a sequence-matched database annotation citing a mutagenesis reference; the supplied excerpts do not independently establish the experiment's outcome.",
    "The option describes the glycyl thioester intermediate rather than explicitly naming cysteine as the residue type."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The other options are inconsistent with the sequence length or with the residue and mechanism at the stated position."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates position 113 as the active site for a glycyl thioester intermediate. Its cited reference concerns mutagenesis of Cys-113, though the supplied excerpts do not give the experimental result itself; the annotation is curator-supported rather than direct experimental evidence shown here.",
    "evidence_ids": ["C5", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The input sequence is 161 residues long, and position 113 is cysteine. A catalytic cysteine can form a thioester with a substrate's terminal glycine, making B a coherent transferable biochemical inference. Positions 1142 and 4261 are outside the sequence, while position 154 is tyrosine, which is a poor fit for the stated nucleophile role.",
    "missing_item_specific_fact": "",
    "reason": "The sequence and the thioester mechanism described in the choices provide a meaningful basis for preferring B without needing the target's database record. This supports a plausible inference, not independent confirmation of the particular protein's activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The other options are inconsistent with the sequence length or with the residue and mechanism at the stated position."
  },
  "important_caveats": [
    "The evidence supports a sequence-matched database annotation citing a mutagenesis reference; the supplied excerpts do not independently establish the experiment's outcome.",
    "The option describes the glycyl thioester intermediate rather than explicitly naming cysteine as the residue type."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A1I1NU27 annotates position 113 as 'Glycyl thioester intermediate' active site (evidence_id C5, H3). The evidence code is ECO:0000305 (inferred by similarity), but the cited reference (Hoer et al., Nature 2024, PubMed:39020165) explicitly mentions 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113' (evidence_id C6, H2), indicating experimental support through mutagenesis. Position 113 in the provided sequence is indeed Cysteine (C), consistent with a thioester-forming catalytic residue in E2-like enzymes.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein is only 161 residues long, immediately eliminating options C (position 1142) and D (position 4261) as physically impossible. Between A (position 154, 'Nucleophile') and B (position 113, 'Glycyl thioester intermediate'): a thioester intermediate chemically requires a sulfur-containing nucleophile, specifically a cysteine residue. Inspecting the sequence, position 113 is C (Cysteine) while position 154 is D (Aspartate). E2-like ubiquitin/ubiquitin-like conjugating enzymes universally use a catalytic cysteine to form a thioester intermediate with the substrate — this is a deeply conserved mechanistic feature across the E1/E2/E3 cascade in eukaryotes and analogous bacterial systems. The term 'glycyl thioester intermediate' specifically describes the mechanism of ubiquitin-like protein conjugation where the C-terminal glycine forms a thioester with the E2's active-site cysteine. A knowledgeable model can (1) eliminate out-of-range positions, (2) recognize that thioester chemistry mandates cysteine, and (3) verify position 113 is C while position 154 is D.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The elimination of C and D is trivial (sequence length). The distinction between A and B relies on general biochemical knowledge: thioester intermediates require cysteine, and E2-like enzymes use catalytic cysteines. This is transferable knowledge about enzyme mechanisms and amino acid chemistry, not a fact unique to this exact protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options C and D are impossible (positions exceed the 161-residue sequence). Between A and B, the thioester chemistry requirement for cysteine uniquely identifies position 113 (C) over position 154 (D). No ambiguity remains.


### Important caveats

- The UniProt annotation uses ECO:0000305 (inferred by similarity), but the primary reference includes mutagenesis data for Cys-113, providing experimental corroboration.
- Options C and D (positions 1142 and 4261) are absurdly out of range for a 161-residue protein, making them trivially eliminable and reducing the effective discrimination to A vs. B.
- The protein is annotated as a 'Bacterial E2-like ubiquitin protein BilB' from Collimonas sp., a recently characterized system (2024 Nature paper), so this is not a well-known textbook enzyme but the mechanistic principle (catalytic cysteine for thioester intermediates in E2-like enzymes) is broadly conserved.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein is only 161 residues long, immediately eliminating options C (position 1142) and D (position 4261) as physically impossible. Between A (position 154, 'Nucleophile') and B (position 113, 'Glycyl thioester intermediate'): a thioester intermediate chemically requires a sulfur-containing nucleophile, specifically a cysteine residue. Inspecting the sequence, position 113 is C (Cysteine) while position 154 is D (Aspartate). E2-like ubiquitin/ubiquitin-like conjugating enzymes universally use a catalytic cysteine to form a thioester intermediate with the substrate — this is a deeply conserved mechanistic feature across the E1/E2/E3 cascade in eukaryotes and analogous bacterial systems. The term 'glycyl thioester intermediate' specifically describes the mechanism of ubiquitin-like protein conjugation where the C-terminal glycine forms a thioester with the E2's active-site cysteine. A knowledgeable model can (1) eliminate out-of-range positions, (2) recognize that thioester chemistry mandates cysteine, and (3) verify position 113 is C while position 154 is D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The elimination of C and D is trivial (sequence length). The distinction between A and B relies on general biochemical knowledge: thioester intermediates require cysteine, and E2-like enzymes use catalytic cysteines. This is transferable knowledge about enzyme mechanisms and amino acid chemistry, not a fact unique to this exact protein's annotation."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1NU27 annotates position 113 as 'Glycyl thioester intermediate' active site (evidence_id C5, H3). The evidence code is ECO:0000305 (inferred by similarity), but the cited reference (Hoer et al., Nature 2024, PubMed:39020165) explicitly mentions 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113' (evidence_id C6, H2), indicating experimental support through mutagenesis. Position 113 in the provided sequence is indeed Cysteine (C), consistent with a thioester-forming catalytic residue in E2-like enzymes."
  },
  "important_caveats": [
    "The UniProt annotation uses ECO:0000305 (inferred by similarity), but the primary reference includes mutagenesis data for Cys-113, providing experimental corroboration.",
    "Options C and D (positions 1142 and 4261) are absurdly out of range for a 161-residue protein, making them trivially eliminable and reducing the effective discrimination to A vs. B.",
    "The protein is annotated as a 'Bacterial E2-like ubiquitin protein BilB' from Collimonas sp., a recently characterized system (2024 Nature paper), so this is not a well-known textbook enzyme but the mechanistic principle (catalytic cysteine for thioester intermediates in E2-like enzymes) is broadly conserved."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are impossible (positions exceed the 161-residue sequence). Between A and B, the thioester chemistry requirement for cysteine uniquely identifies position 113 (C) over position 154 (D). No ambiguity remains."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1NU27 annotates position 113 as 'Glycyl thioester intermediate' active site (evidence_id C5, H3). The evidence code is ECO:0000305 (inferred by similarity), but the cited reference (Hoer et al., Nature 2024, PubMed:39020165) explicitly mentions 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113' (evidence_id C6, H2), indicating experimental support through mutagenesis. Position 113 in the provided sequence is indeed Cysteine (C), consistent with a thioester-forming catalytic residue in E2-like enzymes.",
    "evidence_ids": ["C5", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The protein is only 161 residues long, immediately eliminating options C (position 1142) and D (position 4261) as physically impossible. Between A (position 154, 'Nucleophile') and B (position 113, 'Glycyl thioester intermediate'): a thioester intermediate chemically requires a sulfur-containing nucleophile, specifically a cysteine residue. Inspecting the sequence, position 113 is C (Cysteine) while position 154 is D (Aspartate). E2-like ubiquitin/ubiquitin-like conjugating enzymes universally use a catalytic cysteine to form a thioester intermediate with the substrate — this is a deeply conserved mechanistic feature across the E1/E2/E3 cascade in eukaryotes and analogous bacterial systems. The term 'glycyl thioester intermediate' specifically describes the mechanism of ubiquitin-like protein conjugation where the C-terminal glycine forms a thioester with the E2's active-site cysteine. A knowledgeable model can (1) eliminate out-of-range positions, (2) recognize that thioester chemistry mandates cysteine, and (3) verify position 113 is C while position 154 is D.",
    "missing_item_specific_fact": "",
    "reason": "The elimination of C and D is trivial (sequence length). The distinction between A and B relies on general biochemical knowledge: thioester intermediates require cysteine, and E2-like enzymes use catalytic cysteines. This is transferable knowledge about enzyme mechanisms and amino acid chemistry, not a fact unique to this exact protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are impossible (positions exceed the 161-residue sequence). Between A and B, the thioester chemistry requirement for cysteine uniquely identifies position 113 (C) over position 154 (D). No ambiguity remains."
  },
  "important_caveats": [
    "The UniProt annotation uses ECO:0000305 (inferred by similarity), but the primary reference includes mutagenesis data for Cys-113, providing experimental corroboration.",
    "Options C and D (positions 1142 and 4261) are absurdly out of range for a 161-residue protein, making them trivially eliminable and reducing the effective discrimination to A vs. B.",
    "The protein is annotated as a 'Bacterial E2-like ubiquitin protein BilB' from Collimonas sp., a recently characterized system (2024 Nature paper), so this is not a well-known textbook enzyme but the mechanistic principle (catalytic cysteine for thioester intermediates in E2-like enzymes) is broadly conserved."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A1I1NU27",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "benchmark_sequence_length": 161,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 12,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2017-11-22",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "current_source_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "current_source_sequence_length": 161,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 11,
  "selected_historical_version": {
    "accession": "A0A1I1NU27",
    "database": "Swiss-Prot",
    "entryVersion": 11,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "BILB_COLS4",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "selected_historical_source_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "selected_historical_source_sequence_length": 161,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 11,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A1I1NU27\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":12,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2017-11-22\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Betaproteobacteria\",\"Burkholderiales\",\"Oxalobacteraceae\",\"Collimonas\"],\"scientificName\":\"Collimonas sp. (strain OK412)\",\"taxonId\":1801619}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"value\":\"E2 ubiquitin-conjugating enzyme BilB\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"2.3.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"Bacterial E2-like ubiquitin protein BilB\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/features/1",
  "excerpt": "{\"description\":\"Glycyl thioester intermediate\",\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"location\":{\"end\":{\"modifier\":\"EXACT\",\"value\":113},\"start\":{\"modifier\":\"EXACT\",\"value\":113}},\"type\":\"Active site\"}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Hoer J.\",\"Wolf S.G.\",\"Sorek R.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39020165\"},{\"database\":\"DOI\",\"id\":\"10.1038/s41586-024-07616-5\"}],\"citationType\":\"journal article\",\"firstPage\":\"850\",\"id\":\"39020165\",\"journal\":\"Nature\",\"lastPage\":\"856\",\"publicationDate\":\"2024\",\"title\":\"Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly.\",\"volume\":\"631\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PROBABLE ACTIVE SITE\",\"MUTAGENESIS OF CYS-113\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   BILB_COLS4              Reviewed;         161 AA.\nAC   A0A1I1NU27;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   22-NOV-2017, sequence version 1.\nDT   28-JAN-2026, entry version 11.\nDE   RecName: Full=Bacterial E2-like ubiquitin protein BilB {ECO:0000303|PubMed:39020165};\nDE            EC=2.3.2.- {ECO:0000305|PubMed:39020165};\nDE   AltName: Full=E2 ubiquitin-conjugating enzyme BilB;\nGN   Name=bilB {ECO:0000303|PubMed:39020165};\nGN   ORFNames=SAMN04515619_11957 {ECO:0000312|EMBL:SFD01174.1};\nOS   Collimonas sp. (strain OK412).\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Betaproteobacteria;\nOC   Burkholderiales; Oxalobacteraceae; Collimonas.\nOX   NCBI_TaxID=1801619;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 20-26",
  "excerpt": "RN   [2]\nRP   FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113.\nRX   PubMed=39020165; DOI=10.1038/s41586-024-07616-5;\nRA   Hoer J., Wolf S.G., Sorek R.;\nRT   \"Bacteria conjugate ubiquitin-like proteins to interfere with phage\nRT   assembly.\";\nRL   Nature 631:850-856(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 69-71",
  "excerpt": "FT   ACT_SITE        113\nFT                   /note=\"Glycyl thioester intermediate\"\nFT                   /evidence=\"ECO:0000305|PubMed:39020165\"\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 14. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
